Pseudotime analysis revealed that estrogen and progesterone might drive the occurrence and development of uterine leiomyoma and GO enrichment analysis validated that ERK1/ERK2 signaling pathway might be a critical participator during the process. The gene discussed is MAPK3; the disease is uterine corpus leiomyoma.